Latest Ratios: P/E Ratio -0.5x · EV/EBITDA N/A · ROE -128.0%. (1996–2025 historical series)
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $9M | $7M | $22M | $42M | $42M | $476M | — | — | — | — | — |
| Enterprise Value | $19M | $18M | $30M | $46M | $42M | $478M | — | — | — | — | — |
| P/E Ratio → | -0.54 | — | — | — | — | — | — | — | — | — | — |
| P/S Ratio | 68.56 | 56.41 | 1045.31 | 343.99 | 12.01 | 800.19 | — | — | — | — | — |
| P/B Ratio | 1.06 | 0.93 | 1.40 | 1.72 | 1.22 | 46.66 | — | — | — | — | — |
| P/FCF | — | — | — | — | — | — | — | — | — | — | — |
| P/OCF | — | — | — | — | — | — | — | — | — | — | — |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 141.65 | 1436.41 | 377.39 | 11.85 | 803.34 | — | — | — | — | — |
| EV / EBITDA | — | — | — | — | — | — | — | — | — | — | — |
| EV / EBIT | — | — | — | — | — | — | — | — | — | — | — |
| EV / FCF | — | — | — | — | — | — | — | — | — | — | — |
Margins and return-on-capital ratios measuring operating efficiency
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | -3767.2% | -3767.2% | -153.7% | -207.8% | 39.9% | 69.0% | 31.9% | 25.2% | 16.5% | 76.0% | — |
| Operating Margin | -11268.3% | -11268.3% | -66772.2% | -10815.0% | -397.1% | -650.5% | -8696.7% | -13472.1% | -1717.2% | -231.0% | — |
| Net Profit Margin | -11897.0% | -11897.0% | -71702.3% | -11277.0% | -398.0% | -654.0% | -8758.2% | -13487.2% | -1722.3% | -246.0% | — |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -128.0% | -128.0% | -74.4% | -46.6% | -62.5% | -83.1% | — | -551.9% | -222.9% | -131.1% | — |
| ROA | -59.5% | -59.5% | -49.0% | -39.9% | -35.9% | -18.9% | -338.6% | -153.6% | -71.3% | -44.8% | -231.1% |
| ROIC | -50.2% | -50.2% | -39.8% | -31.7% | -45.5% | -47.7% | — | — | — | — | — |
| ROCE | -62.7% | -62.7% | -50.0% | -40.5% | -62.3% | -82.4% | — | -551.2% | -222.3% | -123.1% | — |
Solvency and debt-coverage ratios — lower is generally safer
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 1.45 | 1.45 | 0.77 | 0.24 | 0.04 | 0.36 | — | — | 0.70 | 1.88 | — |
| Debt / EBITDA | — | — | — | — | — | — | — | — | — | — | — |
| Net Debt / Equity | — | 1.40 | 0.52 | 0.17 | -0.02 | 0.18 | — | — | -1.05 | -2.32 | — |
| Net Debt / EBITDA | — | — | — | — | — | — | — | — | — | — | — |
| Debt / FCF | — | — | — | — | — | — | — | — | — | — | — |
| Interest Coverage | -19.65 | -19.65 | -23.11 | -94.50 | -260.67 | -207.07 | -141.39 | -1785.78 | -336.78 | -15.41 | -232.36 |
Short-term solvency ratios and asset-utilisation metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.06 | 1.06 | 1.10 | 1.85 | 1.15 | 0.07 | 0.07 | 0.59 | 1.78 | 1.14 | 0.21 |
| Quick Ratio | 0.78 | 0.78 | 1.06 | 1.72 | 0.91 | 0.07 | 0.07 | 0.59 | 1.78 | 1.13 | 0.19 |
| Cash Ratio | 0.39 | 0.39 | 0.98 | 1.41 | 0.75 | 0.06 | 0.02 | 0.54 | 1.74 | 1.09 | 0.11 |
| Asset Turnover | — | 0.01 | 0.00 | 0.00 | 0.09 | 0.01 | 0.06 | 0.02 | 0.05 | 0.11 | — |
| Inventory Turnover | 16.24 | 16.24 | 0.37 | 2.24 | 3.55 | — | 3.73 | 2.12 | — | 2.66 | 1.77 |
| Days Sales Outstanding | — | 0.06 | 0.99 | 1.36 | 20.90 | — | — | — | — | — | — |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — | — | — | — | — | — | — |
| Payout Ratio | — | — | — | — | — | — | — | — | — | — | — |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | — | — | — | — | — | — | — | — | — | — | — |
| FCF Yield | — | — | — | — | — | — | — | — | — | — | — |
| Buyback Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — | — | — | — | — |
| Total Shareholder Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — | — | — | — | — |
| Shares Outstanding | — | $4M | $10M | $4M | $3M | $2M | $543079 | $2M | $2M | $2M | $1M |
Imminent liquidity insolvency risk
According to recent market data, Ainos trades at a price-to-sales multiple of 63.09, a figure that appears detached from the company's negligible revenue base and suggests investors are pricing in speculative optionality rather than any tangible fundamental performance or established commercial trajectory in the diagnostic sector.
The elevated P/S ratio reflects a market valuation that is entirely decoupled from the firm's current inability to generate meaningful top-line growth. This valuation suggests that the market is assigning value to the company's intellectual property portfolio rather than its operational output, which warrants extreme caution given the lack of commercial scale.
As reported in financial statements, the company's ROIC has consistently remained in negative territory, reaching -10.7% in 2026Q1, which indicates that every dollar of capital deployed into the business is currently destroying shareholder value rather than generating any form of sustainable economic return.
The persistent negative return on capital is a direct consequence of high R&D spending that has yet to yield a commercially viable product. This trend suggests that the company is failing to achieve the necessary efficiency to justify its ongoing capital requirements, leaving little evidence of a path toward compounding returns.
Based on quarterly filings, the company's asset turnover remains effectively at zero, highlighting a structural inability to convert its asset base into revenue, while the erratic nature of its inventory and receivables management suggests a lack of a cohesive, repeatable operational cycle for its diagnostic products.
The absence of meaningful asset turnover confirms that the company's infrastructure is currently underutilized and disconnected from market demand. Investors should monitor whether the firm can transition from a prototype-heavy model to one that demonstrates basic operational efficiency, as current metrics suggest a significant disconnect between investment and output.
As indicated by the company's reported figures, the debt-to-equity ratio has climbed to 1.93 in 2026Q1, a concerning trend that suggests the firm is increasingly relying on external leverage to fund its operations in the absence of internal cash generation or a stable revenue stream.
The rising leverage, combined with deeply negative interest coverage, indicates that the company's ability to service its obligations is severely compromised. This reliance on debt in a pre-revenue state significantly elevates the risk of insolvency and suggests that future financing will likely be highly dilutive to existing shareholders.
Market participants often rely on the price-to-book ratio of 0.98 to suggest the stock is undervalued, yet this metric is fundamentally misleading for Ainos because the book value is heavily inflated by intangible assets and goodwill that lack clear, realizable market value in a liquidation scenario.
Using P/B as a valuation anchor obscures the reality that the company's assets are primarily tied to unproven R&D projects rather than tangible, productive capital. A more appropriate focus would be the cash burn rate relative to total liquidity, which provides a more accurate assessment of the company's survival risk.
Includes 30+ ratios · 30 years · Updated daily
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying AIMD stock.
Ainos, Inc.'s current P/E ratio is -0.5x. This places it at the 50th percentile of its historical range.
Ainos, Inc.'s return on equity (ROE) is -128.0%. The historical average is -92.5%.
Based on historical data, Ainos, Inc. is trading at a P/E of -0.5x. This is at the 50th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
Ainos, Inc. has -3767.2% gross margin and -11268.3% operating margin.